1
Martin D Burke, David M Knapp, Eric P Gillis: Slow release of organoboronic acids in cross-coupling reactions. Board of Trustees of the University of Illinois, Alan W Steele, Foley Hoag, December 25, 2012: US08338601 (5 worldwide citation)

A method of performing a chemical reaction includes reacting a compound selected from the group consisting of an organohalide and an organo-pseudohalide, and a protected organoboronic acid represented by formula (I) in a reaction mixture: R1—B-T  (I); where R1 represents an organic group, T represen ...


2
Martin D Burke, Eric P Gillis, Suk Joong Lee, David M Knapp, Kaitlyn C Gray: System for controlling the reactivity of boronic acids. The Board of Trustees of the University of Illinois, Alan W Steele, Foley Hoag, September 6, 2011: US08013203 (4 worldwide citation)

A protected organoboronic acid includes a boron having an sp3 hybridization, a conformationally rigid protecting group bonded to the boron, and an organic group bonded to the boron through a boron-carbon bond. A method of performing a chemical reaction includes contacting a protected organoboronic a ...


3

4
Sheldon Hiebert, Ramkumar Rajamani, Li Qiang Sun, Eric Mull, Eric P Gillis, Michael S Bowsher, Qian Zhao, Nicholas A Meanwell, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, P V K Suresh Babu, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, February 17, 2015: US08957203 (1 worldwide citation)

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


5
Martin D Burke, Eric P Gillis: System for controlling the reactivity of boronic acids. The Board of Trustees of the University of Illinois, Alan W Steele, Foley Hoag, November 27, 2012: US08318983 (1 worldwide citation)

A protected organoboronic acid includes a boron having an sp3 hybridization, a conformationally rigid protecting group bonded to the boron, and an organic group bonded to the boron through a boron-carbon bond. A method of performing a chemical reaction includes contacting a protected organoboronic a ...


6
Martin D Burke, David M Knapp, Eric P Gillis: Slow release of organoboronic acids in cross-coupling reactions. The Board of Trustees of the University of Illinois, Dana M Gordon, Foley Hoag, April 14, 2015: US09006463 (1 worldwide citation)

A method of performing a chemical reaction includes reacting a compound selected from the group consisting of an organohalide and an organo-pseudohalide, and a protected organoboronic acid represented by formula (I) in a reaction mixture: R1—B-T  (I); where R1 represents an organic group, T represen ...


7
Li Qiang Sun, Eric P Gillis, Eric Mull, Michael S Bowsher, Qian Zhao, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, March 21, 2017: US09598433

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


8
Eric P Gillis, Michael S Bowsher, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, May 10, 2016: US09334279

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


9
Li Qiang Sun, Qian Zhao, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, Eric P Gillis, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, May 9, 2017: US09643999

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


10
Sheldon Hiebert, Ramkumar Rajamani, Li Qiang Sun, Eric Mull, Eric P Gillis, Michael S Bowsher, Qian Zhao, Nicholas A Meanwell, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, P V K Suresh Babu, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, December 27, 2016: US09527885

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.